Literature DB >> 6865644

Ethynylestradiol-17 beta D-ring glucuronide conjugates are potent cholestatic agents in the rat.

M Vore, H Hadd, W Slikker.   

Abstract

17 alpha-Ethynylestradiol-17 beta (beta-D-glucuronide) [EE217 beta (beta G)], a metabolite of 17 alpha-ethynylestradiol (EE2) identified in urine of women taking EE2 in oral contraceptives, and its synthetic anomer, 17 alpha-ethynylestradiol-17 beta (alpha-D-glucuronide), [EE217 beta (alpha G)], were administered intravenously to female rats in order to determine their effects on bile flow. Both agents induced an immediate, profound and dose-dependent decrease in bile flow which returned to control levels within 1-8 hr. The logarithm of the dose vs the cholestatic response curves for the two anomers were not parallel. EE217 beta (alpha G) was significantly more potent than EE217 beta (beta G) such that the doses inhibiting bile flow by 50% were 1.25 and 11 mumol/kg for the alpha-and beta-anomer respectively.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865644     DOI: 10.1016/0024-3205(83)90650-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.

Authors:  Daniel Y Hung; Gerhard A Siebert; Ping Chang; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  The pathophysiological significance of increased tight-junctional permeability during oestrogen cholestasis.

Authors:  H Jaeschke
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  Oestradiol 17 beta-glucuronide increases tight-junctional permeability in rat liver.

Authors:  K S Kan; M J Monte; R A Parslow; R Coleman
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 4.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.